Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
Condition: Pregnancy Prevention Interventions: Drug: Levonorgestrel 1.5mg; Drug: Meloxicam 15 mg; Other: Placebo Sponsors: InnovaGyn, Inc.; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials